xavionlifesciences

About Us

Welcome to Xavion Lifesciences LLC

Advancing Pharmaceutical Innovation from Concept to Commercialization

Established in 2026 and headquartered in, USA Xavion Lifesciences LLC is committed to advancing global healthcare through cutting-edge pharmaceutical research and development. Our U.S. operations are conducted under Axar Laboratories Inc., our wholly owned subsidiary, expanding our global reach and impact. Our India operations are currently managed under an exclusive development service agreement with Xavion.

We specialize in end-to-end pharmaceutical development, providing comprehensive solutions from Concept to Commercialization (C2C). Our expertise spans formulation development, process optimization, analytical services, clinical trials, regulatory strategy, intellectual property management, packaging, and sourcing. Whether launching a new product or enhancing an existing one, we provide a seamless journey from idea to market.

Our Mission & Vision

Our Vision

“To be the preferred partner in pharmaceutical contract development, driving transformative advancements in drug development and shaping the future of healthcare through excellence, integrity, and innovation.”

Our Mission

“Empowering pharmaceutical innovation through expert contract development solutions, driving advancements in healthcare for a better tomorrow.”

Why Us?

Why Us — Xavion Lifesciences LLC

Experienced Leadership

Our leadership team brings over 200 years of collective hands-on pragmatic pharmaceutical R&D expertise. Supported by a robust scientific team proficient in Product Selection/Development, IP Development, Clinical/Regulatory Excellence, and Project Management.

Streamlined Development & Comprehensive Coverage

Our process emphasizes efficiency, resulting in accelerated time-to-market and reduced development costs for our clients.

Special Focus

We excel in the development of complex generics and advanced drug-device combinations. Our expertise covers Ophthalmic, Nasals, Inhalations, Injectables, Oral Liquids, Topicals, and Oral Solids, delivering innovative formulations like MDPF designs, sustained-release infusions, and taste-masked liquids

Scientific Team

Our robust team of 40+ experts excel in Product Selection/Development, IP Development, Clinical/Regulatory Excellence and Project Management.

Proven Track Record

Demonstrated a track record of innovation and successful market entries, from pioneering product launches and strategic asset divestitures to achieving rapid NDA approvals and advancing complex drug-device combinations, cornerstone for value-creation components/initiatives.